Complementary Signaling through flt3 and Interleukin-7 Receptor α Is Indispensable for Fetal and Adult B Cell Genesis

Journal of Experimental Medicine

Volumn 198, Issue 10, 2003, Pages 1495-1506

  Sitnicka, Ewa ^a   Brakebusch, Cord ^b   Martensson, Inga Lill ^c   Svensson, Marcus ^d   Agace, William W ^d   Sigvardsson, Mikael ^a   Buza Vidas, Natalija ^a   Bryder, David ^a   Cilio, Corrado M ^a   Ahlenius, Henrik ^a   Maraskovsky, Eugene ^e   Peschon, Jacques J ^f   Jacobsen, Sten Eirik W ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c BABRAHAM INSTITUTE   (United Kingdom)

^d LUND UNIVERSITY   (Sweden)

^e LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^f AMGEN INC   (United States)

Author keywords

B1 cells; Flt3 ligand; IL 7 receptor; Lymphopoiesis; Pax5

Indexed keywords

CYTOKINE RECEPTOR; FLT3 LIGAND; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR ALPHA; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; FETUS; GENE TARGETING; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PEYER'S PATCHES; RECEPTORS, INTERLEUKIN-7; SIGNAL TRANSDUCTION;

EID: 10744221710     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20031152     Document Type: Article

References (66)

1. Morrison, S.J., N. Uchida, and I.L. Weissman. 1995. The biology of hematopoietic stem cells. Annu. Rev. Cell Dev. Biol. 11:35-71.
2. Ogawa, M. 1993. Differentiation and proliferation of hematopoietic stem cells. Blood. 81:2844-2853.
3. Metcalf, D. 1993. Hematopoietic regulators: redundancy or subtlety? Blood. 82:3515-3523.
4. Zhu, J., and S.G. Emerson. 2002. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene. 21:3295-3313.
5. Lotem, J., and L. Sachs. 2002. Cytokine control of developmental programs in normal hematopoiesis and leukemia. Oncogene. 21:3284-3294.
6. Schorle, H., T. Holtschke, T. Hunig, A. Schimpl, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature. 352:621-624.
7. Lantz, C.S., J. Boesiger, C.H. Song, N. Mach, T. Kobayashi, R.C. Mulligan, Y. Nawa, G. Dranoff, and S.J. Galli. 1998. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature. 392:90-93.
8. Kuhn, R., K. Rajewsky, and W. Muller. 1991. Generation and analysis of interleukin-4 deficient mice. Science. 254:707-710.
9. von Freeden-Jeffry, U., P. Vieira, L.A. Lucian, T. McNeil, S.E. Burdach, and R. Murray. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1519-1526.
10. Stanley, E., G.J. Lieschke, D. Grail, D. Metcalf, G. Hodgson, J.A. Gall, D.W. Maher, J. Cebon, V. Sinickas, and A.R. Dunn. 1994. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA. 91:5592-5596.
11. Lieschke, G.J., D. Grail, G. Hodgson, D. Metcalf, E. Stanley, C. Cheers, K.J. Fowler, S. Basu, Y.F. Zhan, and A.R. Dunn. 1994. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 84:1737-1746.
12. Bunting, S., R. Widmer, T. Lipari, L. Rangell, H. Steinmetz, K. Carver-Moore, M.W. Moore, G.A. Keller, and F.J. de Sauvage. 1997. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin. Blood. 90:3423-3429.
13. Gurney, A.L., K. Carver-Moore, F.J. de Sauvage, and M.W. Moore. 1994. Thrombocytopenia in c-mpl-deficient mice. Science. 265:1445-1447.
14. Kaushansky, K., N. Fox, N.L. Lin, and W.C. Liles. 2002. Lineage-specific growth factors can compensate for stem and progenitor cell deficiencies at the postprogenitor cell level: an analysis of doubly TPO- and G-CSF receptor-deficient mice. Blood. 99:3573-3578.
15. Gainsford, T., A.W. Roberts, S. Kimura, D. Metcalf, G. Dranoff, R.C. Mulligan, C.G. Begley, L. Robb, and W.S. Alexander. 1998. Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production. Blood. 91:2745-2752.
16. Gainsford, T., H. Nandurkar, D. Metcalf, L. Robb, C.G. Begley, and W.S. Alexander. 2000. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor. Blood. 95:528-534.
17. Chen, Q., G. Solar, D.L. Eaton, and F.J. de Sauvage. 1998. IL-3 does not contribute to platelet production in c-Mpl-deficient mice. Stem Cells. 16:31-36.
18. Scott, C.L., L. Robb, R. Mansfield, W.S. Alexander, and C.G. Begley. 2000. Granulocyte-macrophage colony-stimulating factor is not responsible for residual thrombopoiesis in mpl null mice. Exp. Hematol. 28:1001-1007.
19. Liu, F., J. Poursine-Laurent, H.Y. Wu, and D.C. Link. 1997. Interleukin-6 and the granulocyte colony-stimulating factor receptor are major independent regulators of granulopoiesis in vivo but are not required for lineage commitment or terminal differentiation. Blood. 90:2583-2590.
20. Seymour, J.F., G.J. Lieschke, D. Grail, C. Quilici, G. Hodgson, and A.R. Dunn. 1997. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Blood. 90:3037-3049.
21. Gillessen, S., N. Mach, C. Small, M. Mihm, and G. Dranoff. 2001. Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity. Blood. 97:922-928.
22. Nishinakamura, R., N. Nakayama, Y. Hirabayashi, T. Inoue, D. Aud, T. McNeil, S. Azuma, S. Yoshida, Y. Toyoda, K. Arai, et al. 1995. Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal. Immunity. 2:211-222.
23. Robb, L., C.C. Drinkwater, D. Metcalf, R. Li, F. Kontgen, N.A. Nicola, and C.G. Begley. 1995. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc. Natl. Acad. Sci. USA. 92:9565-9569.
24. Nishinakamura, R., A. Miyajima, P.J. Mee, V.L. Tybulewicz, and R. Murray. 1996. Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions. Blood. 88:2458-2464.
25. Hardy, R.R. 2003. B-cell commitment: deciding on the players. Curr. Opin. Immunol. 15:158-165.
26. Peschon, J.J., P.J. Morrissey, K.H. Grabstein, F.J. Ramsdell, E. Maraskovsky, B.C. Gliniak, L.S. Park, S.F. Ziegler, D.E. Williams, C.B. Ware, et al. 1994. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180:1955-1960.
27. Maki, K., S. Sunaga, Y. Komagata, Y. Kodaira, A. Mabuchi, H. Karasuyama, K. Yokomuro, J.I. Miyazaki, and K. Ikuta. 1996. Interleukin 7 receptor-deficient mice lack gammadelta T cells. Proc. Natl. Acad. Sci. USA. 93:7172-7177.
28. Carvalho, T.L., T. Mota-Santos, A. Cumano, J. Demengeot, and P. Vieira. 2001. Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7(-/)- mice. J. Exp. Med. 194:1141-1150.
29. Miller, J.P., D. Izon, W. DeMuth, R. Gerstein, A. Bhandoola, and D. Allman. 2002. The earliest step in B lineage differentiation from common lymphoid progenitors is critically dependent upon interleukin 7. J. Exp. Med. 196:705-711.
30. Maraskovsky, E., J.J. Peschon, H. McKenna, M. Teepe, and A. Strasser. 1998. Overexpression of Bcl-2 does not rescue impaired B lymphopoiesis in IL-7 receptor-deficient mice but can enhance survival of mature B cells. Int. Immunol. 10:1367-1375.
31. Cao, X., E.W. Shores, J. Hu-Li, M.R. Anver, B.L. Kelsall, S.M. Russell, J. Drago, M. Noguchi, A. Grinberg, E.T. Bloom, et al. 1995. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity. 2:223-238.
32. DiSanto, J.P., W. Muller, D. Guy-Grand, A. Fischer, and K. Rajewsky. 1995. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc. Natl. Acad. Sci. USA. 92:377-381.
33. Kishimoto, T., T. Taga, and S. Akira. 1994. Cytokine signal transduction. Cell. 76:253-262.
34. Lyman, S.D., and S.E. Jacobsen. 1998. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood. 91:1101-1134.
35. Wasserman, R., Y.S. Li, and R.R. Hardy. 1995. Differential expression of the blk and ret tyrosine kinases during B lineage development is dependent on Ig rearrangement. J. Immunol. 155:644-651.
36. McKenna, H.J., K.L. Stocking, R.E. Miller, K. Brasel, T. De Smedt, E. Maraskovsky, C.R. Maliszewski, D.H. Lynch, J. Smith, B. Pulendran, et al. 2000. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood. 95:3489-3497.
37. Sitnicka, E., D. Bryder, K. Theilgaard-Monch, N. Buza-Vidas, J. Adolfsson, and S.E. Jacobsen. 2002. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity. 17:463-472.
38. Mackarehtschian, K., J.D. Hardin, K.A. Moore, S. Boast, S.P. Goff, and I.R. Lemischka. 1995. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity. 3:147-161.
39. Veiby, O.P., S.D. Lyman, and S.E. Jacobsen. 1996. Combined signaling through interleukin-7 receptors and flt3 but not c-kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells. Blood. 88:1256-1265.
40. Cumano, A., K. Dorshkind, S. Gillis, and C.J. Paige. 1990. The influence of S17 stromal cells and interleukin 7 on B cell development. Eur. J. Immunol. 20:2183-2189.
41. Svensson, M., J. Marsal, A. Ericsson, L. Carramolino, T. Broden, G. Marquez, and W.W. Agace. 2002. CCL25 mediates the localization of recently activated CD8alphabeta(+) lymphocytes to the small-intestinal mucosa. J. Clin. Invest. 110:1113-1121.
42. Engvall, E., and P. Perlman. 1971. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry. 8:871-874.
43. Schlissel, M.S., L.M. Corcoran, and D. Baltimore. 1991. Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription. J. Exp. Med. 173:711-720.
44. Adachi, S., H. Yoshida, K. Honda, K. Maki, K. Saijo, K. Ikuta, T. Saito, and S.I. Nishikawa. 1998. Essential role of IL-7 receptor alpha in the formation of Peyer's patch anlage. Int. Immunol. 10:1-6.
45. Rolink, A., E. ten Boekel, F. Melchers, D.T. Fearon, I. Krop, and J. Andersson. 1996. A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors. J. Exp. Med. 183:187-194.
46. Macpherson, A.J., L. Hunziker, K. McCoy, and A. Lamarre. 2001. IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms. Microbes Infect. 3:1021-1035.
47. Rothstein, T.L. 2002. Cutting edge commentary: two B-1 or not to be one. J. Immunol. 168:4257-4261.
48. Martin, F., and J.F. Kearney. 2001. B1 cells: similarities and differences with other B cell subsets. Curr. Opin. Immunol. 13:195-201.
49. Hardy, R.R., C.E. Carmack, S.A. Shinton, J.D. Kemp, and K. Hayakawa. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1213-1225.
50. Li, Y.S., R. Wasserman, K. Hayakawa, and R.R. Hardy. 1996. Identification of the earliest B lineage stage in mouse bone marrow. Immunity. 5:527-535.
51. Schebesta, M., B. Heavey, and M. Busslinger. 2002. Transcriptional control of B-cell development. Curr. Opin. Immunol. 14:216-223.
52. Adams, B., P. Dorfler, A. Aguzzi, Z. Kozmik, P. Urbanek, I. Maurer-Fogy, and M. Busslinger. 1992. Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev. 6:1589-1607.
53. Urbanek, P., Z.Q. Wang, I. Fetka, E.F. Wagner, and M. Busslinger. 1994. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell. 79:901-912.
54. Nutt, S.L., B. Heavey, A.G. Rolink, and M. Busslinger. 1999. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature. 401:556-562.
55. Kozmik, Z., S. Wang, P. Dorfler, B. Adams, and M. Busslinger. 1992. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell. Biol. 12:2662-2672.
56. Fitzsimmons, D., W. Hodsdon, W. Wheat, S.M. Maira, B. Wasylyk, and J. Hagman. 1996. Pax-5 (BSAP) recruits Ets protooncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev. 10:2198-2211.
57. Nutt, S.L., P. Urbanek, A. Rolink, and M. Busslinger. 1997. Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev. 11:476-491.
58. Nutt, S.L., A.M. Morrison, P. Dorfler, A. Rolink, and M. Busslinger. 1998. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J. 17:2319-2333.
59. Hirayama, F., and M. Ogawa. 1996. Cytokine regulation of early lymphohematopoietic development. Stem Cells. 14:369-375.
60. Park, L.S., U. Martin, K. Garka, B. Gliniak, J.P. Di Santo, W. Muller, D.A. Largaespada, N.G. Copeland, N.A. Jenkins, A.G. Farr, et al. 2000. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: formation of a functional heteromeric complex requires interleukin 7 receptor. J. Exp. Med. 192:659-670.
61. Mikkola, I., B. Heavey, M. Horcher, and M. Busslinger. 2002. Reversion of B cell commitment upon loss of Pax5 expression. Science. 297:110-113.
62. Corcoran, L., I. Ferrero, D. Vremec, K. Lucas, J. Waithman, M. O'Keeffe, L. Wu, A. Wilson, and K. Shortman. 2003. The lymphoid past of mouse plasmacytoid cells and thymic dendritic cells. J. Immunol. 170:4926-4932.
63. Adolfsson, J., O.J. Borge, D. Bryder, K. Theilgaard-Monch, I. Astrand-Grundstrom, E. Sitnicka, Y. Sasaki, and S.E. Jacobsen. 2001. Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c- kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity. 15:659-669.
64. Rodewald, H.R., M. Ogawa, C. Haller, C. Waskow, and J.P. DiSanto. 1997. Pro-thymocyte expansion by c-kit and the common cytokine receptor gamma chain is essential for repertoire formation. Immunity. 6:265-272.
65. Fry, T.J., and C.L. Mackall. 2002. Interleukin-7: from bench to clinic. Blood. 99:3892-3904.
66. Lansford, R., J.P. Manis, E. Sonoda, K. Rajewsky, and F.W. Alt. 1998. Ig heavy chain class switching in Rag-deficient mice. Int. Immunol. 10:325-332.